Vertex Pharmaceuticals Incorporated shares owned by Rockefeller Capital Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Rockefeller Capital Management
from 13F filings
Historical chart of Rockefeller Capital Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Rockefeller Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $36M | 93k | 391.63 |
| 2025-06-30 | $44M | 100k | 445.25 |
| 2025-03-31 | $44M | 91k | 484.88 |
| 2024-12-31 | $40M | 99k | 402.75 |
| 2024-09-30 | $33M | 71k | 460.94 |
| 2024-06-30 | $33M | 71k | 464.26 |
| 2024-03-31 | $29M | 70k | 418.01 |
| 2023-12-31 | $25M | 61k | 406.89 |
| 2023-09-30 | $18M | 53k | 348.28 |
| 2023-06-30 | $18M | 51k | 351.91 |
| 2023-03-31 | $14M | 46k | 315.05 |
| 2022-12-31 | $14M | 48k | 288.56 |
| 2022-09-30 | $14M | 48k | 289.32 |
| 2022-06-30 | $11M | 43k | 250.00 |
| 2022-03-31 | $7.4M | 37k | 200.00 |
| 2021-12-31 | $6.0M | 30k | 200.00 |
| 2021-09-30 | $3.4M | 24k | 142.86 |
| 2021-06-30 | $3.5M | 17k | 200.00 |
| 2021-03-31 | $3.8M | 19k | 205.13 |
| 2020-12-31 | $2.5M | 12k | 218.18 |
| 2020-09-30 | $3.0M | 11k | 272.10 |
| 2020-06-30 | $3.0M | 11k | 290.29 |
| 2020-03-31 | $2.0M | 8.2k | 237.89 |
| 2019-12-31 | $488k | 2.2k | 218.74 |
| 2019-09-30 | $342k | 2.0k | 169.22 |
| 2019-06-30 | $274k | 1.5k | 183.16 |
| 2019-03-31 | $487k | 2.7k | 180.00 |
| 2018-12-31 | $93k | 582 | 160.00 |
| 2018-09-30 | $10k | 50 | 200.00 |
| 2018-06-30 | $8.0k | 50 | 160.00 |
More positions owned by Rockefeller Capital Management
View all positions for Rockefeller Capital Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated